How to Buy Evolent Health Stock
Evolent Health Inc
Evolent Health is a health information service company located in Virginia, United States, which is part of the Healthcare sector, and is traded under the ticker EVH on the NYSE exchange.
Evolent Health stock last closed at $9.02, down 3.11% from the previous day, and has decreased 70.08% in one year. It has underperformed other stocks in the Health Information Services industry by 0.15 percentage points. Evolent Health stock is currently +27.76% from its 52-week low of $7.06, and -71.64% from its 52-week high of $31.80.
There are currently 117.51M shares of EVH outstanding. The market cap of EVH is $1.06B. In the last 24 hours, 1.38M EVH shares were traded.
How to Buy Evolent Health Stock
Wondering how to invest in Evolent Health stock? Here's how.
- Choose where to buy Evolent Health stock: You need to decide on an online brokerage, but don't worry - we've tried dozens of online stock brokerages and apps to help you decide where to buy Evolent Health stock.
- Open a brokerage account: Sign up for 0% fee trading with the highest-rated brokerage we've found.
- Deposit money your investment account: Choose your payment method and add your info.
- Research Evolent Health stock: The Evolent Health ticker symbol is EVH. Is Evolent Health stock a good investment? Should you buy shares of EVH? How do EVH's underlying business fundamentals look? Do top analysts think Evolent Health is a good buy? Why has EVH's stock price moved recently? (Hint: Our stock market research tools can help you evaluate if EVH is a good stock to buy).
- Place your EVH trade: Decide if you will purchase EVH shares at the current market price or use a limit order to buy EVH shares at a particular price.
- Get notifications regarding your EVH position: Create a watchlist to key updates about your investment in Evolent Health stock.
Step 1: Choose where to buy Evolent Health stock
You will need a brokerage account to access the NYSE market and buy EVH shares.
Our recommended brokerage: eToro
Based on our analysis, eToro is the best brokerage. eToro gives you:
- Invest in stocks with zero commissions: Invest without paying trading commissions.
- Buy fractional shares: Even if you can't afford a full share, you can still invest in the stock.
- Access to global markets: From Tech to Utilities, New York to Tokyo (for US users, only US stocks are available) — you can fill your portfolio with stocks from the globe's leading exchanges.
- Social investing: eToro boasts a community with more than 20 million users globally. Talk to, learn from, and copy the crypto trades of other investors.
- Security: eToro is a regulated and licensed brokerage platform.
- Buy other financial assets: Such as ETFs and cryptos.
Get $10 towards your purchase of stock by signing up for an account with eToro now. This offer is only for US users.
Open eToro AccountStep 2: Open a brokerage account
Now that you've chosen your brokerage, you'll need to fill out some personal information so you are able to invest in EVH today.
How to Set Up a New Account on eToro
- Click here to get started.eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
- Provide your personal details to create a new trading account.
- Send your information by pressing the "Create Account" button. Get started with eToro today
Step 3: Deposit money your investment account
Now that you have opened your account on a good stock buying app, your next step is to transfer the money for your investment:
Watch the walkthrough below for more details depositing money into your new investment account.
Step 4: Research Evolent Health stock
After you have figured out the best place to buy Evolent Health stock, it's important to evaluate their stock prior to investing, so you actually comprehend the risk and opportunity.
Evolent Health Metrics
Evolent Health Due Diligence Checks
WallStreetZen was built to help part-time investors do better fundamental analysis in less time.
You can view all of the due diligence checks on EVH's stock page.
Is EVH stock properly valued?
Analysts use many financial metrics, analyses, models, and charts to gauge EVH's fair value.
Using relative valuations ratios:
- EVH could be undervalued based on its P/B ratio of 1.18x, relative to Health Information Services industry P/B ratio of 4.11x
You can access more valuation research on EVH's stock here.
How do EVH Financials look?
Positive Financial Indicators:
- EVH has cash burn of 63135000. It has enough cash and short-term investments to cover this for at least one year.
- EVH has $177.97M in cash and short term investments. This is sufficient to cover its annual cash burn of $63.14M.
- There are more short-term assets than short-term liabilities on the EVH balance sheet.
Negative Financial Indicators:
- Total EVH debt is higher than 5 years ago, relative to shareholder equity.
- EVH has a relatively high debt to equity ratio of 1.49.
- EVH profit margin has gone down from -4.5% to -8.4% in the past year.
- There are more long-term liabilities than short-term assets on the EVH balance sheet.
Is Evolent Health stock a Buy, Hold, or Sell, according to analysts?
Out of 7 Wall Street analysts who track EVH, the consensus analyst rating on EVH is a Strong Buy
It's important to note that analyst ratings are not recommendations, nor are they investment advice.
Most Recent EVH Analyst Upgrades/Downgrades
Ryan MacDonald, a top 17% analyst from Needham reiterates EVH with a buy rating and maintains their EVH price target from $15.00 to $15.00, on May 13, 2025.
Kevin Caliendo, a top 17% analyst from UBS maintains EVH with a strong buy rating and raises their EVH price target from $14.00 to $15.00, on May 9, 2025.
UBS's Kevin Caliendo raised their price target on Evolent Health (NYSE: EVH) by 7.1% from $14 to $15 on 2025/05/10. The analyst maintained their Strong Buy rating on the stock.
Evolent Health reported its Q1 2025 earnings.
Five months after repricing and recontracting with its biggest customers, Evolent Health can now show a clearer picture of its future finances and growth algorithm, Caliendo told readers.
According to the analyst, the risk-reward ratio was positive in Q1, which was a good start toward winning back the trust of shareholders.
Earnings Report
For Q1 2025, Evolent Health commented:
- EPS of $0.06, which missed the Zacks Consensus Estimate of $0.09 and, by 82.4%, Q1 2024’s $0.34.
- Revenue of $483.65M, which beat the Zacks Consensus Estimate by 4.76% and, by 24.4%, Q1 2024’s $639.65M.
Management guided:
For Q2 2025:
- Revenue of $440M to $470M.
For FY 2025:
- Revenue of $2.06B to $2.11B.
Co-Founder & CEO Seth Blackley commented: "Evolent Health kicked off 2025 with Q1 results at the high end of our expectations, and we are reiterating our outlook for FY 2025 revenue and Adjusted EBITDA.
“We continue to see a very strong selling environment, and we achieved significant organic growth with five new revenue agreements announced today.
“Operationally, we continue scaling our innovative oncology condition management solution to help Evolent further impact specialty care member experience, costs, and outcomes. “Performance Suite margins, including leading indicators on utilization, and AI-based automation initiatives, like Auth Intel, are both currently tracking favorably.
“From an innovation perspective, we remain focused on improving member and provider experience in specialty care, while continuing to manage affordability for the system – a combination we believe Evolent is uniquely positioned to deliver.
“In the time ahead, we'll remain disciplined in capital allocation, prioritizing cash generation and debt paydown.
“I am proud of our recent progress and I believe that our strong pipeline, low market penetration, innovative product stack and highly engaged team of 4,500 professionals, positions Evolent to deliver sustained value to our shareholders, partners and members in the short and long term."
You can dig deeper into what analysts are projecting on the Evolent Health stock forecast page.
EVH Technical Indicators
Is EVH Making Money?
Last year, EVH revenue was $2.20B. In the last five year, EVH's revenue has grown by 24.44% per year. This was slower than the Health Information Services industry average of 24.49%.
You can research EVH's earnings and revenue performance here.
What are EVH executives and large shareholders up to?
In the last year, executives and large shareholders at EVH have sold more shares than they have bought.
Aammaad Shams, Chief Accounting Officer of EVH, was the latest EVH insider to sell. They sold $25,618.66 worth of EVH stock on Aug 1, 2025.
Research more about who owns EVH shares here.
Does EVH stock generate passive income?
No, Evolent Health doesn't provide an income stream by paying out dividends.
What others are saying about EVH
One of the reasons eToro is our top-rated brokerage is because of its social trading community.
Click below to see what other investors have to say.
Step 5: Place your EVH trade
There are two primary order types:
- Market order: A market order is an order to buy or sell a stock at the best price on the market.
Market orders are usually the easiest way to buy. - Limit order: A limit order allows you to buy or sell a stock at a specific price (or better).
If you want to be sure you're buying or selling at a given price limit, place a limit order.
Click the Open Trade button and eToro will execute the order.
If you require additional assistance buying stocks on eToro, click the helpful video below:
Step 6: Get notifications regarding your EVH position
Now that you own some shares in EVH, you'll want to keep up with your new company.
Create a watchlist to track your EVH stock.
EVH Feed
How to Buy Stock in Evolent Health
To summarize, here are the 6 steps to buy stock in Evolent Health:
- Choose where to buy Evolent Health stock
- Open a brokerage account
- Deposit money your investment account
- Research Evolent Health stock
- Place your EVH trade
- Get notifications regarding your EVH position
If you are looking for a brokerage account, eToro is our favorite venue.
Get Started with eToro TodayIf you would like to get notifications regarding your investment in Evolent Health, add EVH to your watchlist by clicking the button below.
Related "How To" Guides
FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterInformation is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.